NPPB, natriuretic peptide B, 4879

N. diseases: 193; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype RGD Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. 22071162 2012
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype LHGDN Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients. 19262210 2009
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 AlteredExpression phenotype LHGDN Circulating CD34-positive cell number is associated with brain natriuretic peptide level in type 2 diabetic patients. 17959862 2008
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype LHGDN BNP or NTproBNP? A clinician's perspective. 18378336 2008
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype LHGDN Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure. 18037739 2007
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 AlteredExpression phenotype LHGDN Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. 16377932 2006
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype CTD_human Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. 16689991 2006
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype LHGDN Usefulness of B-type natriuretic peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus. 15525883 2004
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype LHGDN Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. 15277419 2004
CUI: C0242698
Disease: Ventricular Dysfunction, Left
Ventricular Dysfunction, Left
0.580 Biomarker phenotype LHGDN Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. 12832317 2003